/clinical/,/clinical/cckm-tools/,/clinical/cckm-tools/content/,/clinical/cckm-tools/content/order-sets/,/clinical/cckm-tools/content/order-sets/inpatient/,/clinical/cckm-tools/content/order-sets/inpatient/bmtoncologyhematology/,

/clinical/cckm-tools/content/order-sets/inpatient/bmtoncologyhematology/name-97843-en.cckm

201606170

page

100

UWHC,UWMF,

Clinical Hub,UW Health Clinical Tool Search,UW Health Clinical Tool Search,Order Sets,Inpatient,BMT/Oncology/Hematology

IP - Factor 8 - Recombinant (HELIXATE FS) - Endoscopy - Supplemental [1081]

IP - Factor 8 - Recombinant (HELIXATE FS) - Endoscopy - Supplemental [1081] - Clinical Hub, UW Health Clinical Tool Search, UW Health Clinical Tool Search, Order Sets, Inpatient, BMT/Oncology/Hematology


IP - Factor 8 Recombinant (HELIXATE FS) - Endoscopy [1081]
Factor 8 Recombinant
Nursing Communication [16515]
Use Hospital Supply of Factor 8 While Inpatient
[NURTRT0048]
CONTINUOUS, Starting today, Use hospital supply of Factor
8 while inpatient.
Avoid Dividing Vial of Factor [NURTRT0048] CONTINUOUS, Starting today, Avoid dividing a vial of factor.
To avoid wasting factor the dose may be rounded up to the
nearest vial size. The final dose should not exceed 125% of
the recommended dose.
Do NOT Administer Any Aspirin Containing Products or
Ketorolac [NURTRT0048]
CONTINUOUS, Starting today, Do NOT administer any
Aspirin containing products or ketorolac.
Medications - Preprocedure
Preprocedure [13684]
factor 8 (HELIXATE FS) injection [760282] 40-50 Units/kg, Intravenous, ONCE For 1 Doses
Give 30 minutes prior to procedure. Use hospital supply of
factor 8 while inpatient. Avoid dividing a vial of factor. To
avoid wasting factor the dose may be rounded to the nearest
vial size. The final dose should not exceed 125% of the
recommended dose.
Note: No aspirin or ketorolac [950018] EVERY 8 HOURS
No aspirin or ketorolac
Medications - Post Endoscopy
Postprocedure - NOTE: Order for procedure with NO banding, cutting or cautery [13685]
factor 8 (HELIXATE FS) injection KIT [760282] 25-30 Units/kg, Intravenous, EVERY 24 HOURS Starting
tomorrow For 2 Doses
Begin 24 hours after preprocedure dose. Use hospital supply
of factor 8 while inpatient. Avoid dividing a vial of factor. To
avoid wasting factor the dose may be rounded to the nearest
vial size. The final dose should not exceed 125% of the
recommended dose.
Postprocedure - Note: Order for procedure with banding [13645]
factor 8 (HELIXATE FS) injection KIT [760282] 25-30 Units/kg, Intravenous, EVERY 24 HOURS For 3 Doses
Begin 24 hours after preprocedure dose. Use hospital supply
of factor 8 while inpatient. Avoid dividing a vial of factor. To
avoid wasting factor the dose may be rounded to the nearest
vial size. The final dose should not exceed 125% of the
recommended dose.
Postprocedure - NOTE: Order BOTH for procedure with cutting or cautery [19680]
factor 8 (HELIXATE FS) injection [760282] 40-50 Units/kg, Intravenous, EVERY 24 HOURS Starting
tomorrow For 2 Doses
Begin 24 hours after preprocedure dose. Use hospital supply
of factor 8 while inpatient. Avoid dividing a vial of factor. To
avoid wasting factor the dose may be rounded to the nearest
vial size. The final dose should not exceed 125% of the
recommended dose.
factor 8 (HELIXATE FS) injection KIT [760282] 25-30 Units/kg, Intravenous, EVERY 24 HOURS Starting
9/8/13 For 12 Doses
Begin 24 hours after previous dose. Use hospital supply of
factor 8 while inpatient. Avoid dividing a vial of factor. To
avoid wasting factor the dose may be rounded to the nearest
vial size. The final dose should not exceed 125% of the
recommended dose.
Page 1 of 1
Pr i nted by STRAKA, KEVIN F [KFS1] at 9/5/2013 10:25:48 AM
Copyright © 2013 University of Wisconsin Hospital and Clinics Authority